Bristol Myers Squibb (CELG-RI) Asset Utilization Ratio (2009 - 2026)

Bristol Myers Squibb has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.55 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 6.69% year-over-year to 0.55; the TTM figure through Mar 2026 stood at 0.55 (up 6.69% YoY), while the FY2025 annual figure was 0.53, up 2.58% from the prior year.
• Asset Utilization Ratio rose to 0.55 in Q1 2026, from 0.52 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for CELG-RI reached as high as 0.55 in Q1 2026 and fell as low as 0.44 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.48 (2023), against an average of 0.49.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio increased 19.29% — and 2024, when it retreated 2.26%.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.47 in 2022, then advanced by 2.0% to 0.48 in 2023, then advanced by 7.4% to 0.52 in 2024, then decreased by 0.57% to 0.52 in 2025, then advanced by 6.53% to 0.55 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.55, 0.52, and 0.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.